Commerzbank Aktiengesellschaft’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-320,000
Closed -$304K 856
2019
Q2
$304K Buy
+320,000
New +$7.6M ﹤0.01% 849
2019
Q1
Sell
-342,500
Closed -$1.42M 877
2018
Q4
$1.42M Buy
342,500
+120,000
+54% +$2.85M 0.01% 477
2018
Q3
$303K Buy
222,500
+207,500
+1,383% +$4.75M ﹤0.01% 787
2018
Q2
$80K Buy
+15,000
New +$310K ﹤0.01% 880
2015
Q1
Sell
-100,000
Closed -$14.3M 1155
2014
Q4
$14.3M Buy
+100,000
New +$13.5M 0.09% 192

Other funds holding BHC

Commerzbank Aktiengesellschaft's BHC Position: Q2 2020 in Review

Commerzbank Aktiengesellschaft sold out of Bausch Health (BHC) in Q2 2020, closing a stake of 46,947 shares — an estimated $728K sold.

Commerzbank Aktiengesellschaft first reported a position in BHC in Q2 2013 and held it in 28 quarters. The position peaked at $26.6M in Q2 2019. 303 funds tracked by Wall St. Rank hold BHC as of Q2 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Bausch Health position as of Q2 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 46,947 Bausch Health shares in Q2 2020, an estimated $728K.
  • Commerzbank Aktiengesellschaft first reported a position in Bausch Health in Q2 2013 and held it in 28 quarters.
  • Commerzbank Aktiengesellschaft's Bausch Health position peaked at $26.6M in Q2 2019.
  • 303 funds tracked by Wall St. Rank held Bausch Health as of Q2 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2020, filed 21 Jul 2020.